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Objectives: Peripheral facial palsy (PFP) is a disorder of com-
mon neural causes that are still unknown. Other possible causes 
include vascular disorders, inflammatory and immunological 
factors, and possibly viral infections. According to the literature 
there is an association between the incidence of PFP and diabetes 
mellitus (DM), a disease which is known to cause neuropathies. 
The objective of this study is to evaluate the outcome of patients 
with concomitant DM and PFP, as well as to compare the evolu-
tion of these patients compared to patients without DM and PFP 
through clinical, laboratory, and electrophysiological tests.
Methods: An observational case-control study. Outpatient 
follow-up between 2011-2012 of 50 patients according to the 
presence or absence of PFP and DM that were divided into 4 
groups and matched. All patients underwent the following 
tests: tearing (Schirmer’s test), tonal and speech audiometry, 
tympanometry with reflex of the stapedius muscle, Test 
Hilger, and glucose analysis.
Results: The rate of complete recovery considered grade I or 
II of the House-Brackman classification at the end of 6 months 
of follow-up showed that 58.4% of diabetic patients presented 
a good evolution in contrast to 80% of nondiabetics.
Conclusions: In our findings we concluded that diabetic 
patients had a slower recovery time and poor degree of facial 
paralysis when compared to nondiabetics.
The Exclusive Endoscopic Traspromontorial 
Approach and Its Pilot Clinical Experiences
Matteo Alicandri-Ciufelli, MD (presenter); Daniele Marchioni, 
MD; Livio Presutti, MD
Objectives: Describe a minimally invasive transcanal endo-
scopic approach, starting from the external auditory canal and 
reaching the internal auditory canal, used to treat inner ear 
pathology.
Methods: Three patients, affected respectively by cochlear 
schwannoma, acoustic neuroma, and temporal bone choleste-
atoma, were treated by an exclusive endoscopic approach 
without external incisions. Surgical steps and useful land-
marks were reviewed and described.
Results: The operation provided a direct transcochlear intra-
dural approach from lateral to medial and from external to 
internal auditory canal, without any external incision. The 
pathology was totally removed in all patients. Results regard-
ing facial nerve were very satisfying. Hospital stay was mark-
edly reduced compared to traditional approaches.
Conclusions: The transcanal exclusive endoscopic approach 
proved successful for pathology removal involving the fun-
dus, internal auditory canal, and cochlea. Potential future 
application of this kind of approach in lateral skull base sur-
gery will depend on the development of technology and surgi-
cal and anatomical refinements.
Expression of Angiogenic Molecules in 
Cochlear Vasculature
Sungsu Lee, MD, PhD (presenter); Hyong-Ho Cho, MD, PhD
Objectives: (1) Three-dimensionally (3D) visualize the 
cochlear vessels and blood-labyrinth barrier. (2) Analyze the 
expression of angiogenic molecules in cochlear vessels.
Methods: Postnatal day 5 and 8-week old mice were used. 
After obtaining the cochlea, bony shell was removed. Whole 
mount immunostaining was done with endothelial cell marker 
PECAM-1 and VE-cadherin. NG2 and demins were used for 
pericyte marker. aSMA was used as vascular smooth muscle 
cell and S100 was used as fibrocyte marker. 3D reconstruction 
was done to visualize the blood-labyrinth barrier components. 
VEGFR2, VEGFR3, Sox17, angiopoietin-2, Dll4 were used 
for angiogenic markers. Claudin-5 was used to visualize the 
tight junction.
Results: We could visualize the cochlear vasculature in overall, 
from precapillar arteriole, stria vascularis, and postcapillary ven-
ule. The relationship between components of blood-labyrinth 
barrier also could be visualized from basal turn to apical turn of 
the cochlea. Cochlear vessels well expressed VEGFR3, VEGFR2, 
Sox17 in the endothelial cell showing that cochlea is in active 
state, not static. Claudin-5 was robustly expressed suggesting its 
important role in blood-labyrinth barrier. aSMA was well 
expressed demonstrating its need for vessel contraction.
Conclusions: A vessel is not merely a conduit for blood flow. 
It is newly made and is also regressed. It permits or limits 
many molecules on crossing over to the tissue. The cochlear 
vessel is an active vessel. We suggest that visualizing the 
cochlear vessel and checking the expression of angiogenic 
molecules could help understand the pathophysiology in hear-
ing loss models.
Fat Myringoplasty: Better Patient Selection 
for Better Results
Hani F. El Garem, MS (presenter)
Objectives: (1) Evaluate the outcome of fat myringoplasty in 
relation to the perforation size. (2) Compare the outcome in 
relation to 2 fat sources (ear lobule and abdominal wall).
Methods: This study was conducted between May 2012 and 
April 2013 in the ENT department, University of Alexandria, 
Egypt. It was carried out on 30 patients with tympanic mem-
brane perforations <30% of its surface (20 patients with perfo-
rations equal or less than 2 mm and 10 patients with 
perforations exceeding 2 mm in diameter), and with a maxi-
mum air bone gap of 20 dB. There were 2 randomized groups. 
Group A: 15 patients who had myringoplasty with ear lobule 
fat. Group B: 15 patients operated on using abdominal wall 
fat. Patients were followed for 6 months postoperatively.
Results: Among the 20 patients with a perforation size ≤2 
mm, 18 patients (90%) succeeded and 2 (10%) failed. Among 
the 10 patients with a perforation exceeding 2 mm, 5 patients 
(50%) succeeded and 5 (50%) failed. There was a significant 
statistical difference between perforation size and success 
rate. In group A, 12 patients (80%) had successful operations 
and 3 patients (20%) failed. In group B, 11 patients (73.3%) 
were successful and 4 patients (26.7%) failed. There were no 
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